AG
REGN icon

Advisor Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Advisor Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$715K Sell
1,904
-62
-3% -$20.9K ﹤0.01% 1423
2019
Q3 		$545K Sell
1,966
-123
-6% -$36.4K ﹤0.01% 1553
2019
Q2 		$653K Sell
2,089
-445
-18% -$148K 0.01% 1434
2019
Q1 		$1.04M Sell
2,534
-863
-25% -$355K 0.01% 1060
2018
Q4 		$1.27M Buy
3,397
+62
+2% +$22.7K 0.01% 828
2018
Q3 		$1.35M Buy
3,335
+153
+5% +$58.2K 0.01% 819
2018
Q2 		$1.1M Sell
3,182
-39
-1% -$12.2K 0.02% 818
2018
Q1 		$1.11M Buy
3,221
+16
+0.5% +$5.57K 0.02% 805
2017
Q4 		$1.21M Buy
3,205
+164
+5% +$66.4K 0.02% 779
2017
Q3 		$1.36M Buy
3,041
+157
+5% +$74.7K 0.02% 665
2017
Q2 		$1.42M Sell
2,884
-202
-7% -$88.4K 0.02% 600
2017
Q1 		$1.2M Buy
3,086
+275
+10% +$102K 0.02% 630
2016
Q4 		$1.03M Buy
2,811
+129
+5% +$49.1K 0.02% 645
2016
Q3 		$1.08M Sell
2,682
-11
-0.4% -$4.41K 0.03% 609
2016
Q2 		$939K Buy
+2,693
New +$1.04M 0.02% 647

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Advisor Group's REGN Position: Q4 2019 in Review

Advisor Group reduced its Regeneron Pharmaceuticals (REGN) stake by 3.2% in Q4 2019, selling an estimated $20.9K and leaving 1,904 shares worth $715K. The position accounts for ﹤0.01% of the portfolio, ranked #1423.

Advisor Group first reported a position in REGN in Q2 2016 and has held it in 15 quarters since. The position peaked at $1.42M in Q2 2017. 702 funds tracked by Wall St. Rank hold REGN as of Q4 2019.

  • Advisor Group held 1,904 shares of Regeneron Pharmaceuticals worth $715K as of Q4 2019.
  • Advisor Group sold 62 Regeneron Pharmaceuticals shares in Q4 2019, an estimated $20.9K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #1423 holding.
  • Advisor Group first reported a position in Regeneron Pharmaceuticals in Q2 2016 and has held it in 15 quarters since.
  • Advisor Group's Regeneron Pharmaceuticals position peaked at $1.42M in Q2 2017.
  • 702 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.